Environmental Health Perspectives · 2011 · 219 citations · 25 references
MedicineHealth SciencesOncologyCancer EpidemiologyEpidemiologic MethodsEpidemiologyCancer Burden AssessmentCancer IncidenceCancer RiskGlobal EpidemiologyMalignant NeoplasmsAsbestos CoverageAsbestos-related DiseaseGlobal Cancer BurdenGlobal Cancer PrevalenceNational Cancer Burden
BACKGROUND: Little is known about the global magnitude of mesothelioma. In particular, many developing countries, including some with extensive historical use of asbestos, do not report mesothelioma. OBJECTIVES: We estimated the global magnitude of mesothelioma accounting for reported and unreported cases. METHODS: For all countries with available data on mesothelioma frequency and asbestos use (n=56), we calculated the 15-year cumulative number of mesotheliomas during 1994-2008 from data available for fewer years and assessed its relationship with levels of cumulative asbestos use during 1920-1970. We used this relationship to predict the number of unreported mesotheliomas in countries for which no information on mesothelioma is available but which have recorded asbestos use (n=33). RESULTS: Within the group of 56 countries with data on mesothelioma occurrence and asbestos use, the 15-year cumulative number of mesothelioma was approximately 174,300. There was a statistically significant positive linear relation between the log-transformed national cumulative mesothelioma numbers and the log-transformed cumulative asbestos use (adjusted R(2)=0.83, p<0.0001). Extrapolated to the group of 33 countries without reported mesothelioma, a total of approximately 38,900 (95% confidence interval, 36,700-41,100) mesothelioma cases were estimated to have occurred in the 15-year period (1994-2008). CONCLUSIONS: We estimate conservatively that, globally, one mesothelioma case has been overlooked for every four to five reported cases. Because our estimation is based on asbestos use until 1970, the many countries that increased asbestos use since then should anticipate a higher disease burden in the immediate decades ahead.
25
The National Center for Biotechnology Information
D. A. Benson, Mark S. Boguski, David J. Lipman et al. · Genomics · 1990 · 5.2K citations · Full text
The European mesothelioma epidemic
Julian Peto, Adriano Decarli, Carlo La Vecchia et al. · British Journal of Cancer · 1999 · 900 citations · Full text
Medicine, Demography, Oncology +17
Antti Tossavainen · Scandinavian Journal of Work Environment & Health · 1997 · 445 citations · Full text
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
J T Hodgson, Damien McElvenny, Andrew Darnton et al. · British Journal of Cancer · 2005 · 369 citations · Full text
Medicine, Biostatistics, Oncology +17